The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma

Eur Respir J. 2023 Aug 3;62(2):2300245. doi: 10.1183/13993003.00245-2023. Print 2023 Aug.

Authors

Alexandra M Nanzer^{1

2}, Victoria Taylor³, Andrew P Hearn^{3

2}, Joanne E Kavanagh^{3

2}, Tanya Patrick³, Linda Green³, Louise Thomson³, Jodie Lam³, Mariana Fernandes³, Cris Roxas³, Grainne d'Ancona^{3

2}, Brian D Kent^{3

4

5}, Jaideep Dhariwal³, David J Jackson^{3

2}

Affiliations

¹ Guy's Severe Asthma Service, Guy's and St Thomas' NHS Foundation Trust, London, UK [email protected].
² King's Centre for Lung Health, School of Immunology and Microbial Sciences, King's College London, London, UK.
³ Guy's Severe Asthma Service, Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁴ Department of Respiratory Medicine, St James' Hospital, Dublin, Ireland.
⁵ School of Medicine, Trinity College Dublin, Dublin, Ireland.

PMID: 37474156
DOI: 10.1183/13993003.00245-2023

No abstract available

Publication types

Letter

MeSH terms

Asthma* / complications
Asthma* / drug therapy
Biological Therapy
Humans
Obesity / complications
Steroids
Weight Loss

Substances

Steroids